Our director, Frederic Saltel, has been appointed co-chair of the Scientific Council of the French Cancer Society (SFC). The French Cancer Society was founded in 1906—120 years ago! It began as the French Association for the Study of Cancer (AFEC) and, 80 years later, became the...
🎉 Congratulations to the Vizgen Grant winners! To mark the launch of the BRIC RNA EXplore spatial transcriptomics platform, we are pleased to announce that the projects led by Julie Giraud (Team 3), Anissa Zaafour (Team 04), and Ahmad Charanek (Team 01) have been selected for...
On March 19, 2026, BRIC – Bordeaux Institute of Oncology hosted a scientific symposium on 3D models in oncology in Bordeaux. The event brought together numerous researchers, engineers, and clinicians to discuss recent advances in the development and analysis of 3D models applied to cancer research....
A promising breakthrough in the fight against hepatoblastoma Team 6 MIRCADE (Methods and Innovations for Research on Childhood Cancers), led byDr. Christophe Grosset , a Research Director at Inserm, has just published a significant article in the prestigious journal Molecular Cancer, shedding new light on hepatoblastoma,...
On January 31, 2026, we opened our doors to the general public at our premises in the BBS (Bordeaux Biology Health) building on the University of Bordeaux campus. On this occasion, nearly 70 participants attended the Bordeaux Institute of Oncology (BRIC) to discover one of the...
Congratulation to BRIC Team 8 for their last publication in Nature Communications!!! Their study, in collaboration with EFS Nouvelle Aquitaine and Gustave-Roussy Institute genomic platform, introduces a powerful single-cell multiplex platform to sensitively map on-target genotoxic effects of CRISPR-Cas9 genome editing in primary human cells....
BRIC Inserm U1312/ Université de Bordeaux teams at the heart of research at PEDIACRIEX CIRCLE, an INCa-certified center of excellence in pediatric oncology research The French National Cancer Institute (INCa) has just named CIRCLE (Collaboration In between two seas Resistance Cancer Longevity) as the 4th integrated...
Ahmad Sharanek appointed Chargé de Recherche INSERM: a journey of perseverance and continuous improvement BRIC is pleased to congratulate Ahmad Sharanek (also spelled Charanek), researcher in Team 1, on his recent appointment as a "Chargé de Recherche Classe Normale" (CRCN) at Inserm. A well-deserved recognition, following...
From June 4 to 6, 2025, the 11th Congress of the French Society for Angiogenesis (SFA) took place in Autrans (Isère), bringing together researchers, clinicians, and PhD students to discuss the latest advances in vascular biology. On this occasion, Léa Pechtimaldjian, a third-year PhD candidate...
The BRIC recently had the pleasure of receiving renewed support from the Lions Club of Bergerac through the national fundraising initiative "Tulips Against Cancer."This donation supports a fundamental research project led by Team 8 of the BRIC (Biotherapies, Genetics, and Oncology – BIOGO), in collaboration...
